Certificado Even3
100% Online
R$ 29,00
O Coletivo Mulheres nas Quebradas - atua desde 2019, a partir de integrantes do projeto Universidade das Quebradas/PACC/Faculdade de Letras/UFRJ. Busca articulações entre os diversos feminismos e o feminismo orgânico praticado pelas mulheres nos territórios, sedimentado por valores e saberes ancestrais e comunitários. Realiza ações que incentivam mulheres a registrarem suas histórias e memórias e a protagonizarem suas vidas. Empoderar é valorizar e compartilhar para o desenvolvimento do potencial que as mulheres trazem em si e não encontra eco na sociedade excludente. O projeto Livres Livros é uma das iniciativas do nosso Coletivo.
Join us at the 1st Brazilian International Congress of Clinical Analysis and Research - Innovation that Generates Development, based in Recife, Pernambuco, Brazil, January 31- February 10, 2022. Maxiclínica Médica Ltda-ME is proud to hold an online Congress and expects your participation. The focus will be on innovation generating development. Innovation is the introduction of something new, given the scope of its application as a vector for human development and improved quality of life. The world is increasingly technological. For the medical area, health 4.0 is already a reality, since several enterprises adopt state-of-the-art equipment, intuitive interfaces, and integration systems. With the modernization of clinical analysis laboratories, examinations have become faster and more accurate and it remains an essential ally for the development of clinical research, which constitutes one of the priority points for improving the health of the population. The holding of a congress focusing on clinical analysis and interfacing with clinical research, by a private company, Maxiclínica Médica Ltda-ME, opens up new perspectives and contributes to the dissemination of research in Brazil. Maxiclínica Médica Ltda-ME is a day hospital, with specific beds for research, with experience of 73 clinical trials. Revenues from the congress will be reverted to clinical research on the action of cannabinoids in Parkinson's, Alzheimer's and autism, phases II and III.